Type 2 diabetes, a condition marked by chronically high blood sugar levels, is a leading driver of metabolic disease in America. While conventional medical advice recommends taking medications to control blood sugar levels, this is only a temporary measure at best. Diabetes is compounded by several factors, and recent research notes that nutritional deficiencies is… Read More »
Recent advancements in medical science have opened new avenues for treating chronic diseases. A group of Chinese scientists has reportedly cured a 25-year-old woman with type 1 diabetes through a groundbreaking cell transplant procedure. This case, claimed to be the first of its kind globally, marks a significant milestone in diabetes treatment and may offer… Read More »
Nearly half a billion people on the planet have diabetes, but most of them aren’t getting the kind of care that could make their lives healthier, longer and more productive, according to a new global study of data from people with the condition. Many don’t even know they have the condition. Only 1 in 10… Read More »
FDA Approves Zegalogue (dasiglucagon) Injection for the Treatment of Severe Hypoglycemia in People with Diabetes Copenhagen, DK and Boston, MA, U.S. March 22, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company aspiring to deliver innovation with novel peptide therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has approved Zegalogue® (dasiglucagon)… Read More »